Advanced biomaterials and drug delivery systems could improve the potency of cancer immunotherapies while reducing toxicities - find out more in this new review by Rachel Riley, Carl June, Robert Langer and Michael Mitchell https://go.nature.com/2TG3c4f pic.twitter.com/IBOjBj5ZOs
